Targeting AXL Could Slow Metastasis in HER2-Positive Breast Cancer

New research has found that expression of AXL is correlated with poor outcomes in patients with HER2-positive breast cancer.

Source: CancerNetwork - May 14, 2018 Category: Cancer & Oncology Authors: Dave Levitan Tags: Breast Cancer HER2-Positive Breast Cancer SiteTerms/www.cannabissciencetech.com/News Source Type: news